Detailed definition
Menopause-associated hair changes have multiple drivers. Female pattern hair loss (FPHL, also called androgenetic alopecia) often accelerates in midlife as the relative androgen-to-estrogen ratio shifts; affected areas are typically the central scalp and crown. Hair texture changes (dryness, reduced shine) reflect altered sebum production and protein structure. Mild facial hair (chin, upper lip) increase is common as small amounts of androgen become unopposed by estrogen. Workup of significant hair loss includes thyroid function, iron studies (ferritin), and screening for other contributors. Treatment options include topical minoxidil 5% (rogaine), oral spironolactone (anti-androgen), oral finasteride or dutasteride (5α-reductase inhibitors, off-label in women), and platelet-rich plasma. HRT may modestly help in some women but is not a primary hair-loss treatment.
Why it matters in menopause
Hair loss in midlife often has multiple causes and warrants workup beyond reflexive "it must be menopause." Iron deficiency from heavy perimenopausal periods, thyroid disease, and FPHL all contribute and are treatable.
Related terms
Sources
External references: Wikipedia.